Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and 18F-fluoromisonidazole hypoxia imaging in renal cell carcinoma
about
Combining radiotherapy with sunitinib: lessons (to be) learnedPositron emission tomography to assess hypoxia and perfusion in lung cancerMolecular mechanisms of hypoxia in cancer.Dual tracer evaluation of dynamic changes in intratumoral hypoxic and proliferative states after radiotherapy of human head and neck cancer xenografts using radiolabeled FMISO and FLT.Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma.Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinomaHypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors.Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft.Tumor hypoxia: a new PET imaging biomarker in clinical oncology.2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth.Changes in tumor oxygen state after sorafenib therapy evaluated by 18F-fluoromisonidazole hypoxia imaging of renal cell carcinoma xenograftsDetecting functional changes with [(18)F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy.Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation.Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.Imaging the Tumor Microenvironment.Monitoring of tumor vascular normalization: the key points from basic research to clinical applicationHow to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research
P2860
Q26800587-C5190F40-0306-4BD3-8D54-6E003379F5F3Q27026940-606D3E06-7772-465B-B43D-26794888EAFEQ33705108-17BCCC53-C3EA-4280-9C9A-EFAF53856291Q35269132-5DF31C6E-9363-4A84-9F93-95A5AD212660Q36212847-9536776D-42CE-4D5A-8F7C-B7A48344215CQ37049104-7E4F0D02-C447-466A-B2E5-8913D16AE5C9Q37418248-A7315105-07EB-41FE-BE98-1B400CC94D49Q37496766-9D831545-AB1C-49A4-BFBA-6D440C484CC1Q38411275-2A14FA2E-7214-48A2-AA87-2C63B3A26F6BQ38743607-4B6D19F7-A3EE-4D19-9F7F-DBA722A1FAECQ41144790-274E6E95-4F98-4017-9AEF-AA532818FC64Q41505826-D0CBD99B-AFB4-4A30-B63E-31F12BEFBB3FQ41660750-FA3F5817-25DA-4D05-BD76-F3DB0B3FD5A2Q48018285-E3A031B7-958D-4012-8DFE-79F8E78848B0Q49592815-14A4B634-005C-4D76-84D4-3AB3A9B2FEE7Q57484416-1A709A55-C8CA-44C9-A91C-A1C0F7A43678Q58695229-65881EB7-95EF-4DFF-9C13-7CC1711B6A86
P2860
Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and 18F-fluoromisonidazole hypoxia imaging in renal cell carcinoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Evaluation of changes in the t ...... renal cell carcinoma
@en
Evaluation of changes in the t ...... renal cell carcinoma.
@nl
type
label
Evaluation of changes in the t ...... renal cell carcinoma
@en
Evaluation of changes in the t ...... renal cell carcinoma.
@nl
prefLabel
Evaluation of changes in the t ...... renal cell carcinoma
@en
Evaluation of changes in the t ...... renal cell carcinoma.
@nl
P2093
P2860
P356
P1476
Evaluation of changes in the t ...... renal cell carcinoma
@en
P2093
Ken-Ichi Nishijima
Masahiro Murakami
Mitsuyoshi Takiguchi
Nagara Tamaki
Nusrat Fatema Chowdhury
Songji Zhao
P2860
P304
P356
10.3892/IJO.2012.1624
P577
2012-09-10T00:00:00Z